Latest filing published 06 Apr 2011 for Acura Pharmaceuticals, INC, €103k.
Insider track record
No signal scores available.
Andrew D. Reddick: trading record in brief
This profile gathers the share dealings of Andrew D. Reddick in Acura Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 24 April 2009 to 4 April 2011.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 April 2011, the filings show a share grant worth €103k in Acura Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew D. Reddick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 112,500 shares@ US$1.30Common StockSEC:0001209191-11-021960:0
- 30,263 shares@ US$3.90Common StockSEC:0001209191-11-021960:2
- 93,038 shares@ US$3.31Common StockSEC:0001209191-11-001150:0
- 425,000 shares@ US$1.30Common StockSEC:0001209191-09-054466:0
- 129,695 shares@ US$4.26Common StockSEC:0001209191-09-054466:1
- 119,658 shares@ US$4.26Common StockSEC:0001209191-09-054466:2
- 85,000 sharesCommon StockSEC:0001209191-09-022760:0
7 of 7 declarations
